ConductScience.org, home

Paper32915331

The role of neurohormonal blockers in the primary prevention of acute-, early-, and late-onset anthracycline-induced cardiotoxicity.

Ayuna A and 1 other. Egypt Heart J, 2020. Cited by 6 papers, by iCite.

Cite this record

ConductScience Library. The role of neurohormonal blockers in the primary prevention of acute-, early-, and late-onset anthracycline-induced cardiotoxicity. Papers, record 32915331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32915331

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The role of neurohormonal blockers in the primary prevention of acute-, early-, and late-onset anthracycline-induced cardiotoxicity.
PubMed
Journal
Egypt Heart J
PubMed
Year
2020
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
0.24
iCite
Revised in PubMed
2022-04-16
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ayuna AAhmedhttps://orcid.org/0000-0002-2059-8447
2Abidin NNik

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References27

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111928719Beneficial effects of angiotensin-converting enzyme inhibition in adriamycin-induced cardiomyopathy in hamsters.Jpn J Pharmacol2002https://conductscience.org/library/papers/11928719PubMed
230595329Prophylactic use of carvedilol to prevent ventricular dysfunction in patients with cancer treated with doxorubicin.Indian Heart J2018https://conductscience.org/library/papers/30595329PubMed
327893331Multidisciplinary Approach to Novel Therapies in Cardio-Oncology Research (MANTICORE 101-Breast): A Randomized Trial for the Prevention of Trastuzumab-Associated Cardiotoxicity.J Clin Oncol2017https://conductscience.org/library/papers/27893331PubMed
420872550Cardioprotective effect of metoprolol and enalapril in doxorubicin-treated lymphoma patients: a prospective, parallel-group, randomized, controlled study with 36-month follow-up.Am J Hematol2010https://conductscience.org/library/papers/20872550PubMed
517161256Protective effects of carvedilol against anthracycline-induced cardiomyopathy.J Am Coll Cardiol2006https://conductscience.org/library/papers/17161256PubMed
627567406
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC).
Eur Heart J2016https://conductscience.org/library/papers/27567406PubMed
727351173Management strategies and outcomes for very elderly patients with diffuse large B-cell lymphoma.Cancer2016https://conductscience.org/library/papers/27351173PubMed
830009543Role of ACE inhibitors in anthracycline-induced cardiotoxicity: A randomized, double-blind, placebo-controlled trial.Pediatr Blood Cancer2018https://conductscience.org/library/papers/30009543PubMed
928141699Cardioprotective Effects of Carvedilol in Inhibiting Doxorubicin-induced Cardiotoxicity.J Cardiovasc Pharmacol2017https://conductscience.org/library/papers/28141699PubMed
1010933366Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy.J Am Coll Cardiol2000https://conductscience.org/library/papers/10933366PubMed
1129540327Carvedilol for Prevention of Chemotherapy-Related Cardiotoxicity: The CECCY Trial.J Am Coll Cardiol2018https://conductscience.org/library/papers/29540327PubMed
129768828Epidemiology of anthracycline cardiotoxicity in children and adults.Semin Oncol1998https://conductscience.org/library/papers/9768828PubMed
1317101852Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition.Circulation2006https://conductscience.org/library/papers/17101852PubMed
1423583763
Enalapril and carvedilol for preventing chemotherapy-induced left ventricular systolic dysfunction in patients with malignant hemopathies: the OVERCOME trial (preventiOn of left Ventricular dysfunction with Enalapril and caRvedilol in patients submitted to intensive ChemOtherapy for the treatment of Malignant hEmopathies).
J Am Coll Cardiol2013https://conductscience.org/library/papers/23583763PubMed
1522727976Protective effects of nebivolol against anthracycline-induced cardiomyopathy: a randomized control study.Int J Cardiol2013https://conductscience.org/library/papers/22727976PubMed
1627918725Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline.J Clin Oncol2017https://conductscience.org/library/papers/27918725PubMed
1715148277Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy.Circulation2004https://conductscience.org/library/papers/15148277PubMed
1820826257Protective effects of the angiotensin II receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress, and early ventricular impairment.Am Heart J2010https://conductscience.org/library/papers/20826257PubMed
1917070141Serial testing of B-type natriuretic peptide and NTpro-BNP for monitoring therapy of heart failure: the role of biologic variation in the interpretation of results.Am Heart J2006https://conductscience.org/library/papers/17070141PubMed
2029118031
Neurohormonal Blockade and Circulating Cardiovascular Biomarkers During Anthracycline Therapy in Breast Cancer Patients: Results From the PRADA (Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy) Study.
J Am Heart Assoc2017https://conductscience.org/library/papers/29118031PubMed

See all 27 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
40970189Pharmacological interventions to prevent cardiotoxicity in patients undergoing anthracycline-based chemotherapy: a network meta-analysis.Front Cardiovasc Med2025https://conductscience.org/library/papers/40970189PubMed
40387994Evaluation of left atrial strain changes in patients with breast cancer after anthracycline therapy.Egypt Heart J2025https://conductscience.org/library/papers/40387994PubMed
40207253Comprehensive review of non-invasive-treatment-related cardiovascular toxicity in breast cancer.iScience2025https://conductscience.org/library/papers/40207253PubMed
37875715Mesenchymal Stem Cell-Derived Exosomes and Their MicroRNAs in Heart Repair and Regeneration.J Cardiovasc Transl Res2024https://conductscience.org/library/papers/37875715PubMed
35757327Clinical Manifestations, Monitoring, and Prognosis: A Review of Cardiotoxicity After Antitumor Strategy.Front Cardiovasc Med2022https://conductscience.org/library/papers/35757327PubMed
35497981Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms and Strategies for Cardioprotection.Front Cardiovasc Med2022https://conductscience.org/library/papers/35497981PubMed

Download CSV of cited by

Genes6

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ACE1636PubTator's text mininghttps://conductscience.org/library/genes/1636NCBI Gene
CMPK151727PubTator's text mininghttps://conductscience.org/library/genes/51727NCBI Gene
IL63569PubTator's text mininghttps://conductscience.org/library/genes/3569NCBI Gene
NPPB4879PubTator's text mininghttps://conductscience.org/library/genes/4879NCBI Gene
REN5972PubTator's text mininghttps://conductscience.org/library/genes/5972NCBI Gene
TNNI37137PubTator's text mininghttps://conductscience.org/library/genes/7137NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32915331

GET https://conductscience.org/api/papers/v1/32915331/references?page=2